• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 状态对慢性肾脏病中成纤维细胞生长因子 23 和甲状旁腺激素相对增加的影响。

The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.

机构信息

Department of Renal Medicine, Royal Derby Hospital, Derby, UK.

1] Department of Renal Medicine, Royal Derby Hospital, Derby, UK [2] Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Nottingham, UK.

出版信息

Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.

DOI:10.1038/ki.2013.537
PMID:24429404
Abstract

Fibroblast growth factor (FGF) 23 is an important regulator of phosphaturia. Its serum level was found to increase before that of parathyroid hormone (PTH) in early chronic kidney disease (CKD) in some but not all previous studies. As vitamin D insufficiency is associated with elevated PTH, we determined the effect of vitamin D status on FGF23 and PTH levels in relation to glomerular filtration rate (GFR) in people with CKD stage 3. Serum intact FGF23, PTH, and 25(OH)vitamin D3 were measured in 1664 patients who were prospectively recruited from primary care. Mean or median values for key variables were an age of 73 years, estimated GFR (eGFR) of 53 ml/min per 1.73 m(2), PTH 46 pg/ml, FGF23 42 pg/ml, and 25(OH)vitamin D3 53 nmol/l. FGF23 and PTH concentrations were elevated in similar proportions of people with lower eGFR in the whole cohort. However, when 752 people with vitamin D insufficiency or deficiency were excluded, FGF23 was elevated in a greater proportion than PTH at all levels of eGFR. Conversely, among people with vitamin D insufficiency, PTH was elevated in a greater proportion than FGF23 at all GFR levels of ⩾40 ml/min per 1.73 m(2). In this cohort, we were able to triangulate the relationship between 25(OH)vitamin D3, PTH, and FGF23, showing that vitamin D status critically determines whether FGF23 or PTH becomes elevated first in the context of lower GFR. Future studies of FGF23 in people with CKD should routinely determine their vitamin D status.

摘要

成纤维细胞生长因子 23(FGF23)是尿磷排泄的重要调节因子。在一些但并非所有先前的研究中发现,在早期慢性肾脏病(CKD)中,其血清水平在甲状旁腺激素(PTH)之前升高。由于维生素 D 不足与 PTH 升高有关,我们确定了维生素 D 状态对肾小球滤过率(GFR)下降的 CKD 3 期患者的 FGF23 和 PTH 水平的影响。前瞻性地从初级保健中招募了 1664 名患者,检测其血清完整 FGF23、PTH 和 25(OH)维生素 D3。主要变量的平均值或中位数为年龄 73 岁,估计肾小球滤过率(eGFR)为 53ml/min/1.73m2,PTH 为 46pg/ml,FGF23 为 42pg/ml,25(OH)维生素 D3 为 53nmol/L。在整个队列中,eGFR 较低的人群中,FGF23 和 PTH 浓度升高的比例相似。然而,当排除 752 名维生素 D 不足或缺乏的患者时,在所有 eGFR 水平下,FGF23 升高的比例大于 PTH。相反,在维生素 D 不足的人群中,在所有 GFR 水平(≥40ml/min/1.73m2)下,PTH 升高的比例大于 FGF23。在该队列中,我们能够对 25(OH)维生素 D3、PTH 和 FGF23 之间的关系进行三角剖分,表明维生素 D 状态在 GFR 下降的情况下,对 FGF23 或 PTH 哪个先升高具有决定性作用。今后在 CKD 患者中进行 FGF23 的研究应常规确定其维生素 D 状态。

相似文献

1
The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.维生素 D 状态对慢性肾脏病中成纤维细胞生长因子 23 和甲状旁腺激素相对增加的影响。
Kidney Int. 2014 Aug;86(2):407-13. doi: 10.1038/ki.2013.537. Epub 2014 Jan 15.
2
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.在慢性肾脏病3期患者的前瞻性初级保健队列中,成纤维细胞生长因子23、维生素D和甲状旁腺激素与5年预后的相关性。
BMJ Open. 2017 Aug 23;7(8):e016528. doi: 10.1136/bmjopen-2017-016528.
3
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.慢性肾脏病 1 至 5 期的分泌性 Klotho 和 FGF23:一项横断面研究提示的序列。
Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.
4
Regulation of fibroblast growth factor-23 in chronic kidney disease.慢性肾脏病中成纤维细胞生长因子-23的调控
Nephrol Dial Transplant. 2007 Nov;22(11):3202-7. doi: 10.1093/ndt/gfm347. Epub 2007 Jun 13.
5
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.在一项基于人群的老年男性队列研究中,成纤维细胞生长因子-23与甲状旁腺激素及肾功能相关。
Eur J Endocrinol. 2008 Jan;158(1):125-9. doi: 10.1530/EJE-07-0534.
6
Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.慢性肾脏病患者循环 25 羟维生素 D 水平与甲状旁腺激素的关系:阈值得探索。
J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.
7
Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.透析龄和甲状旁腺激素水平,而不是成纤维细胞生长因子 23,决定了肾移植后慢性期磷酸盐的丢失。
Bone. 2012 Oct;51(4):729-36. doi: 10.1016/j.bone.2012.06.027. Epub 2012 Jul 14.
8
Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.维持性肾移植患者血清成纤维细胞生长因子 23 水平。
Nephrol Dial Transplant. 2012 Nov;27(11):4227-35. doi: 10.1093/ndt/gfs409.
9
Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.甲状旁腺激素、成纤维细胞生长因子 23 和磷酸盐重吸收参数。
Am J Nephrol. 2018;47(5):343-351. doi: 10.1159/000489270. Epub 2018 May 18.
10
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.成纤维细胞生长因子23与儿童慢性肾脏病进展风险
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989-1998. doi: 10.2215/CJN.02110216. Epub 2016 Aug 25.

引用本文的文献

1
Beyond secondary hyperparathyroidism: Diagnosing primary parathyroid abnormalities in a patient with chronic kidney disease.超越继发性甲状旁腺功能亢进:诊断慢性肾脏病患者的原发性甲状旁腺异常
Radiol Case Rep. 2024 Sep 25;19(12):6385-6389. doi: 10.1016/j.radcr.2024.08.142. eCollection 2024 Dec.
2
A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.美国和日本慢性肾脏病患者血清磷酸盐及相关参数的比较研究。
Am J Nephrol. 2022;53(2-3):226-239. doi: 10.1159/000521386. Epub 2022 Feb 28.
3
Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together?
维生素 K 和 D 补充与慢性肾脏病的骨骼健康——分开还是一起?
Nutrients. 2021 Mar 1;13(3):809. doi: 10.3390/nu13030809.
4
Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults.横断面评估成年人肾功能不同水平下维生素 D 状态与补充剂使用之间的关系。
BMJ Open. 2019 Feb 22;9(2):e022471. doi: 10.1136/bmjopen-2018-022471.
5
Vitamin D deficiency, endothelial function and bone biomarkers in post-kidney transplantation patients from North India.印度北部肾移植术后患者的维生素D缺乏、内皮功能和骨生物标志物
Int Urol Nephrol. 2019 Jan;51(1):181-186. doi: 10.1007/s11255-018-2014-7. Epub 2018 Nov 19.
6
Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.在阿姆斯特丹纵向老龄化研究中,肾功能与骨密度和骨折风险的关系。
Osteoporos Int. 2018 Sep;29(9):2129-2138. doi: 10.1007/s00198-018-4592-8. Epub 2018 Jun 15.
7
Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.维生素D与肾脏结局:慢性肾脏病-矿物质和骨异常的第四个结局?2015年大岛奖演讲
Clin Exp Nephrol. 2018 Apr;22(2):249-256. doi: 10.1007/s10157-017-1517-3. Epub 2017 Dec 21.
8
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.在慢性肾脏病3期患者的前瞻性初级保健队列中,成纤维细胞生长因子23、维生素D和甲状旁腺激素与5年预后的相关性。
BMJ Open. 2017 Aug 23;7(8):e016528. doi: 10.1136/bmjopen-2017-016528.
9
Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion.提高对胆钙化醇在 CKD 治疗作用的认识:多学科观点。
Endocrine. 2018 Feb;59(2):242-259. doi: 10.1007/s12020-017-1369-3. Epub 2017 Jul 19.
10
Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.维生素D原激素治疗慢性肾脏病患者继发性甲状旁腺功能亢进症。
Int J Nephrol Renovasc Dis. 2017 May 11;10:109-122. doi: 10.2147/IJNRD.S97637. eCollection 2017.